Detalles de la búsqueda
1.
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC).
Circulation
; 148(14): 1113-1126, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37782695
2.
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
Circulation
; 147(25): 1933-1944, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335828
3.
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial.
Am Heart J
; 272: 11-22, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38458371
4.
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.
Circulation
; 145(11): 847-863, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35286164
5.
Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction.
Am Heart J
; 258: 17-26, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36596332
6.
Consensus minimum core data elements adapted to peripheral vascular intervention in the drug-eluting era: Consensus report from the Registry Assessment of Peripheral Interventional Devices (RAPID) Pathways "LEAN" working group.
J Vasc Surg
; 78(5): 1313-1321, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37524153
7.
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.
Circulation
; 143(5): 479-500, 2021 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33523728
8.
Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
N Engl J Med
; 381(21): 2032-2042, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31556978
9.
Randomized evaluation of vessel preparation with orbital atherectomy prior to drug-eluting stent implantation in severely calcified coronary artery lesions: Design and rationale of the ECLIPSE trial.
Am Heart J
; 249: 1-11, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35288105
10.
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction-1-year follow-up results of the COMPARE CRUSH trial.
Am Heart J
; 252: 26-30, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671829
11.
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
Eur Heart J
; 42(45): 4624-4634, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34662382
12.
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
Eur Heart J
; 42(45): 4683-4693, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423374
13.
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.
Circulation
; 142(24): 2316-2328, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33315489
14.
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Circulation
; 141(11): 891-901, 2020 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31992063
15.
Important considerations for trials for peripheral arterial disease: Lessons learned from the paclitaxel mortality signal: A report on behalf of the registry assessment for peripheral interventional Devices (RAPID) Paclitaxel Pathways Program.
Am Heart J
; 232: 71-83, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33157067
16.
Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions.
J Vasc Surg
; 73(5): 1702-1714.e11, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33080324
17.
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.
Catheter Cardiovasc Interv
; 98(6): 1111-1119, 2021 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33038061
18.
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies.
J Thromb Thrombolysis
; 52(2): 419-428, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33709255
19.
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
Eur Heart J
; 41(37): 3533-3545, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085967
20.
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.
Circulation
; 140(3): 240-261, 2019 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31116032